Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Facial Injectables Market Growth 2022-2028

  • LP 4743219
  • 113 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Facial Injectables will have significant change from previous year. According to our (LP Information) latest study, the global Facial Injectables market size is USD million in 2022 from USD 9468.3 million in 2021, with a change of % between 2021 and 2022. The global Facial Injectables market size will reach USD 17500 million in 2028, growing at a CAGR of 9.2% over the analysis period.

The United States Facial Injectables market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Facial Injectables market, reaching US$ million by the year 2028. As for the Europe Facial Injectables landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Facial Injectables players cover Allergan, Merz Aesthetics, Prollenium Medical Technologies, and Bloomega BioTechnology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Facial Injectables market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Botox

Dermal Fillers

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Clinics

Cosmetic Centers

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Allergan

Merz Aesthetics

Prollenium Medical Technologies

Bloomega BioTechnology

Galderma

Ipsen Group

Suneva Medical

Polymekon

Visionmed

Syneron

Medytox

AQTIS Medical

ColBar LifeScience

SciVision Biotech

Hangzhou Techderm Biological Products

Qufu Guanglong Biochem

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Facial Injectables Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Facial Injectables by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Facial Injectables by Country/Region, 2017, 2022 & 2028

2.2 Facial Injectables Segment by Type

2.2.1 Botox

2.2.2 Dermal Fillers

2.2.3 Other

2.3 Facial Injectables Sales by Type

2.3.1 Global Facial Injectables Sales Market Share by Type (2017-2022)

2.3.2 Global Facial Injectables Revenue and Market Share by Type (2017-2022)

2.3.3 Global Facial Injectables Sale Price by Type (2017-2022)

2.4 Facial Injectables Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Cosmetic Centers

2.4.4 Other

2.5 Facial Injectables Sales by Application

2.5.1 Global Facial Injectables Sale Market Share by Application (2017-2022)

2.5.2 Global Facial Injectables Revenue and Market Share by Application (2017-2022)

2.5.3 Global Facial Injectables Sale Price by Application (2017-2022)

3 Global Facial Injectables by Company

3.1 Global Facial Injectables Breakdown Data by Company

3.1.1 Global Facial Injectables Annual Sales by Company (2020-2022)

3.1.2 Global Facial Injectables Sales Market Share by Company (2020-2022)

3.2 Global Facial Injectables Annual Revenue by Company (2020-2022)

3.2.1 Global Facial Injectables Revenue by Company (2020-2022)

3.2.2 Global Facial Injectables Revenue Market Share by Company (2020-2022)

3.3 Global Facial Injectables Sale Price by Company

3.4 Key Manufacturers Facial Injectables Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Facial Injectables Product Location Distribution

3.4.2 Players Facial Injectables Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Facial Injectables by Geographic Region

4.1 World Historic Facial Injectables Market Size by Geographic Region (2017-2022)

4.1.1 Global Facial Injectables Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Facial Injectables Annual Revenue by Geographic Region

4.2 World Historic Facial Injectables Market Size by Country/Region (2017-2022)

4.2.1 Global Facial Injectables Annual Sales by Country/Region (2017-2022)

4.2.2 Global Facial Injectables Annual Revenue by Country/Region

4.3 Americas Facial Injectables Sales Growth

4.4 APAC Facial Injectables Sales Growth

4.5 Europe Facial Injectables Sales Growth

4.6 Middle East & Africa Facial Injectables Sales Growth

5 Americas

5.1 Americas Facial Injectables Sales by Country

5.1.1 Americas Facial Injectables Sales by Country (2017-2022)

5.1.2 Americas Facial Injectables Revenue by Country (2017-2022)

5.2 Americas Facial Injectables Sales by Type

5.3 Americas Facial Injectables Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Facial Injectables Sales by Region

6.1.1 APAC Facial Injectables Sales by Region (2017-2022)

6.1.2 APAC Facial Injectables Revenue by Region (2017-2022)

6.2 APAC Facial Injectables Sales by Type

6.3 APAC Facial Injectables Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Facial Injectables by Country

7.1.1 Europe Facial Injectables Sales by Country (2017-2022)

7.1.2 Europe Facial Injectables Revenue by Country (2017-2022)

7.2 Europe Facial Injectables Sales by Type

7.3 Europe Facial Injectables Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Facial Injectables by Country

8.1.1 Middle East & Africa Facial Injectables Sales by Country (2017-2022)

8.1.2 Middle East & Africa Facial Injectables Revenue by Country (2017-2022)

8.2 Middle East & Africa Facial Injectables Sales by Type

8.3 Middle East & Africa Facial Injectables Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Facial Injectables

10.3 Manufacturing Process Analysis of Facial Injectables

10.4 Industry Chain Structure of Facial Injectables

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Facial Injectables Distributors

11.3 Facial Injectables Customer

12 World Forecast Review for Facial Injectables by Geographic Region

12.1 Global Facial Injectables Market Size Forecast by Region

12.1.1 Global Facial Injectables Forecast by Region (2023-2028)

12.1.2 Global Facial Injectables Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Facial Injectables Forecast by Type

12.7 Global Facial Injectables Forecast by Application

13 Key Players Analysis

13.1 Allergan

13.1.1 Allergan Company Information

13.1.2 Allergan Facial Injectables Product Offered

13.1.3 Allergan Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Main Business Overview

13.1.5 Allergan Latest Developments

13.2 Merz Aesthetics

13.2.1 Merz Aesthetics Company Information

13.2.2 Merz Aesthetics Facial Injectables Product Offered

13.2.3 Merz Aesthetics Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merz Aesthetics Main Business Overview

13.2.5 Merz Aesthetics Latest Developments

13.3 Prollenium Medical Technologies

13.3.1 Prollenium Medical Technologies Company Information

13.3.2 Prollenium Medical Technologies Facial Injectables Product Offered

13.3.3 Prollenium Medical Technologies Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Prollenium Medical Technologies Main Business Overview

13.3.5 Prollenium Medical Technologies Latest Developments

13.4 Bloomega BioTechnology

13.4.1 Bloomega BioTechnology Company Information

13.4.2 Bloomega BioTechnology Facial Injectables Product Offered

13.4.3 Bloomega BioTechnology Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bloomega BioTechnology Main Business Overview

13.4.5 Bloomega BioTechnology Latest Developments

13.5 Galderma

13.5.1 Galderma Company Information

13.5.2 Galderma Facial Injectables Product Offered

13.5.3 Galderma Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Galderma Main Business Overview

13.5.5 Galderma Latest Developments

13.6 Ipsen Group

13.6.1 Ipsen Group Company Information

13.6.2 Ipsen Group Facial Injectables Product Offered

13.6.3 Ipsen Group Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ipsen Group Main Business Overview

13.6.5 Ipsen Group Latest Developments

13.7 Suneva Medical

13.7.1 Suneva Medical Company Information

13.7.2 Suneva Medical Facial Injectables Product Offered

13.7.3 Suneva Medical Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Suneva Medical Main Business Overview

13.7.5 Suneva Medical Latest Developments

13.8 Polymekon

13.8.1 Polymekon Company Information

13.8.2 Polymekon Facial Injectables Product Offered

13.8.3 Polymekon Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Polymekon Main Business Overview

13.8.5 Polymekon Latest Developments

13.9 Visionmed

13.9.1 Visionmed Company Information

13.9.2 Visionmed Facial Injectables Product Offered

13.9.3 Visionmed Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Visionmed Main Business Overview

13.9.5 Visionmed Latest Developments

13.10 Syneron

13.10.1 Syneron Company Information

13.10.2 Syneron Facial Injectables Product Offered

13.10.3 Syneron Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Syneron Main Business Overview

13.10.5 Syneron Latest Developments

13.11 Medytox

13.11.1 Medytox Company Information

13.11.2 Medytox Facial Injectables Product Offered

13.11.3 Medytox Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Medytox Main Business Overview

13.11.5 Medytox Latest Developments

13.12 AQTIS Medical

13.12.1 AQTIS Medical Company Information

13.12.2 AQTIS Medical Facial Injectables Product Offered

13.12.3 AQTIS Medical Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 AQTIS Medical Main Business Overview

13.12.5 AQTIS Medical Latest Developments

13.13 ColBar LifeScience

13.13.1 ColBar LifeScience Company Information

13.13.2 ColBar LifeScience Facial Injectables Product Offered

13.13.3 ColBar LifeScience Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 ColBar LifeScience Main Business Overview

13.13.5 ColBar LifeScience Latest Developments

13.14 SciVision Biotech

13.14.1 SciVision Biotech Company Information

13.14.2 SciVision Biotech Facial Injectables Product Offered

13.14.3 SciVision Biotech Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 SciVision Biotech Main Business Overview

13.14.5 SciVision Biotech Latest Developments

13.15 Hangzhou Techderm Biological Products

13.15.1 Hangzhou Techderm Biological Products Company Information

13.15.2 Hangzhou Techderm Biological Products Facial Injectables Product Offered

13.15.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Hangzhou Techderm Biological Products Main Business Overview

13.15.5 Hangzhou Techderm Biological Products Latest Developments

13.16 Qufu Guanglong Biochem

13.16.1 Qufu Guanglong Biochem Company Information

13.16.2 Qufu Guanglong Biochem Facial Injectables Product Offered

13.16.3 Qufu Guanglong Biochem Facial Injectables Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Qufu Guanglong Biochem Main Business Overview

13.16.5 Qufu Guanglong Biochem Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Facial Injectables Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Facial Injectables Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Botox

Table 4. Major Players of Dermal Fillers

Table 5. Major Players of Other

Table 6. Global Facial Injectables Sales by Type (2017-2022) & (K Pcs)

Table 7. Global Facial Injectables Sales Market Share by Type (2017-2022)

Table 8. Global Facial Injectables Revenue by Type (2017-2022) & ($ million)

Table 9. Global Facial Injectables Revenue Market Share by Type (2017-2022)

Table 10. Global Facial Injectables Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Facial Injectables Sales by Application (2017-2022) & (K Pcs)

Table 12. Global Facial Injectables Sales Market Share by Application (2017-2022)

Table 13. Global Facial Injectables Revenue by Application (2017-2022)

Table 14. Global Facial Injectables Revenue Market Share by Application (2017-2022)

Table 15. Global Facial Injectables Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Facial Injectables Sales by Company (2020-2022) & (K Pcs)

Table 17. Global Facial Injectables Sales Market Share by Company (2020-2022)

Table 18. Global Facial Injectables Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Facial Injectables Revenue Market Share by Company (2020-2022)

Table 20. Global Facial Injectables Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Facial Injectables Producing Area Distribution and Sales Area

Table 22. Players Facial Injectables Products Offered

Table 23. Facial Injectables Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Facial Injectables Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global Facial Injectables Sales Market Share Geographic Region (2017-2022)

Table 28. Global Facial Injectables Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Facial Injectables Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Facial Injectables Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global Facial Injectables Sales Market Share by Country/Region (2017-2022)

Table 32. Global Facial Injectables Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Facial Injectables Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Facial Injectables Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas Facial Injectables Sales Market Share by Country (2017-2022)

Table 36. Americas Facial Injectables Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Facial Injectables Revenue Market Share by Country (2017-2022)

Table 38. Americas Facial Injectables Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas Facial Injectables Sales Market Share by Type (2017-2022)

Table 40. Americas Facial Injectables Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas Facial Injectables Sales Market Share by Application (2017-2022)

Table 42. APAC Facial Injectables Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC Facial Injectables Sales Market Share by Region (2017-2022)

Table 44. APAC Facial Injectables Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Facial Injectables Revenue Market Share by Region (2017-2022)

Table 46. APAC Facial Injectables Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC Facial Injectables Sales Market Share by Type (2017-2022)

Table 48. APAC Facial Injectables Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC Facial Injectables Sales Market Share by Application (2017-2022)

Table 50. Europe Facial Injectables Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe Facial Injectables Sales Market Share by Country (2017-2022)

Table 52. Europe Facial Injectables Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Facial Injectables Revenue Market Share by Country (2017-2022)

Table 54. Europe Facial Injectables Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe Facial Injectables Sales Market Share by Type (2017-2022)

Table 56. Europe Facial Injectables Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe Facial Injectables Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Facial Injectables Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa Facial Injectables Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Facial Injectables Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Facial Injectables Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Facial Injectables Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Facial Injectables Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Facial Injectables Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Facial Injectables Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Facial Injectables

Table 67. Key Market Challenges & Risks of Facial Injectables

Table 68. Key Industry Trends of Facial Injectables

Table 69. Facial Injectables Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Facial Injectables Distributors List

Table 72. Facial Injectables Customer List

Table 73. Global Facial Injectables Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global Facial Injectables Sales Market Forecast by Region

Table 75. Global Facial Injectables Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Facial Injectables Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Facial Injectables Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas Facial Injectables Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Facial Injectables Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC Facial Injectables Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Facial Injectables Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe Facial Injectables Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Facial Injectables Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa Facial Injectables Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Facial Injectables Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global Facial Injectables Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Facial Injectables Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Facial Injectables Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Facial Injectables Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global Facial Injectables Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Facial Injectables Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Facial Injectables Revenue Market Share Forecast by Application (2023-2028)

Table 93. Allergan Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 94. Allergan Facial Injectables Product Offered

Table 95. Allergan Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Allergan Main Business

Table 97. Allergan Latest Developments

Table 98. Merz Aesthetics Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 99. Merz Aesthetics Facial Injectables Product Offered

Table 100. Merz Aesthetics Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Merz Aesthetics Main Business

Table 102. Merz Aesthetics Latest Developments

Table 103. Prollenium Medical Technologies Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 104. Prollenium Medical Technologies Facial Injectables Product Offered

Table 105. Prollenium Medical Technologies Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Prollenium Medical Technologies Main Business

Table 107. Prollenium Medical Technologies Latest Developments

Table 108. Bloomega BioTechnology Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 109. Bloomega BioTechnology Facial Injectables Product Offered

Table 110. Bloomega BioTechnology Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Bloomega BioTechnology Main Business

Table 112. Bloomega BioTechnology Latest Developments

Table 113. Galderma Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 114. Galderma Facial Injectables Product Offered

Table 115. Galderma Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Galderma Main Business

Table 117. Galderma Latest Developments

Table 118. Ipsen Group Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 119. Ipsen Group Facial Injectables Product Offered

Table 120. Ipsen Group Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. Ipsen Group Main Business

Table 122. Ipsen Group Latest Developments

Table 123. Suneva Medical Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 124. Suneva Medical Facial Injectables Product Offered

Table 125. Suneva Medical Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Suneva Medical Main Business

Table 127. Suneva Medical Latest Developments

Table 128. Polymekon Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 129. Polymekon Facial Injectables Product Offered

Table 130. Polymekon Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. Polymekon Main Business

Table 132. Polymekon Latest Developments

Table 133. Visionmed Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 134. Visionmed Facial Injectables Product Offered

Table 135. Visionmed Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. Visionmed Main Business

Table 137. Visionmed Latest Developments

Table 138. Syneron Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 139. Syneron Facial Injectables Product Offered

Table 140. Syneron Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. Syneron Main Business

Table 142. Syneron Latest Developments

Table 143. Medytox Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 144. Medytox Facial Injectables Product Offered

Table 145. Medytox Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 146. Medytox Main Business

Table 147. Medytox Latest Developments

Table 148. AQTIS Medical Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 149. AQTIS Medical Facial Injectables Product Offered

Table 150. AQTIS Medical Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 151. AQTIS Medical Main Business

Table 152. AQTIS Medical Latest Developments

Table 153. ColBar LifeScience Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 154. ColBar LifeScience Facial Injectables Product Offered

Table 155. ColBar LifeScience Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 156. ColBar LifeScience Main Business

Table 157. ColBar LifeScience Latest Developments

Table 158. SciVision Biotech Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 159. SciVision Biotech Facial Injectables Product Offered

Table 160. SciVision Biotech Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 161. SciVision Biotech Main Business

Table 162. SciVision Biotech Latest Developments

Table 163. Hangzhou Techderm Biological Products Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 164. Hangzhou Techderm Biological Products Facial Injectables Product Offered

Table 165. Hangzhou Techderm Biological Products Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 166. Hangzhou Techderm Biological Products Main Business

Table 167. Hangzhou Techderm Biological Products Latest Developments

Table 168. Qufu Guanglong Biochem Basic Information, Facial Injectables Manufacturing Base, Sales Area and Its Competitors

Table 169. Qufu Guanglong Biochem Facial Injectables Product Offered

Table 170. Qufu Guanglong Biochem Facial Injectables Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 171. Qufu Guanglong Biochem Main Business

Table 172. Qufu Guanglong Biochem Latest Developments

List of Figures

Figure 1. Picture of Facial Injectables

Figure 2. Facial Injectables Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Facial Injectables Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Facial Injectables Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Facial Injectables Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Botox

Figure 10. Product Picture of Dermal Fillers

Figure 11. Product Picture of Other

Figure 12. Global Facial Injectables Sales Market Share by Type in 2021

Figure 13. Global Facial Injectables Revenue Market Share by Type (2017-2022)

Figure 14. Facial Injectables Consumed in Hospitals

Figure 15. Global Facial Injectables Market: Hospitals (2017-2022) & (K Pcs)

Figure 16. Facial Injectables Consumed in Clinics

Figure 17. Global Facial Injectables Market: Clinics (2017-2022) & (K Pcs)

Figure 18. Facial Injectables Consumed in Cosmetic Centers

Figure 19. Global Facial Injectables Market: Cosmetic Centers (2017-2022) & (K Pcs)

Figure 20. Facial Injectables Consumed in Other

Figure 21. Global Facial Injectables Market: Other (2017-2022) & (K Pcs)

Figure 22. Global Facial Injectables Sales Market Share by Application (2017-2022)

Figure 23. Global Facial Injectables Revenue Market Share by Application in 2021

Figure 24. Facial Injectables Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Facial Injectables Revenue Market Share by Company in 2021

Figure 26. Global Facial Injectables Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Facial Injectables Revenue Market Share by Geographic Region in 2021

Figure 28. Global Facial Injectables Sales Market Share by Region (2017-2022)

Figure 29. Global Facial Injectables Revenue Market Share by Country/Region in 2021

Figure 30. Americas Facial Injectables Sales 2017-2022 (K Pcs)

Figure 31. Americas Facial Injectables Revenue 2017-2022 ($ Millions)

Figure 32. APAC Facial Injectables Sales 2017-2022 (K Pcs)

Figure 33. APAC Facial Injectables Revenue 2017-2022 ($ Millions)

Figure 34. Europe Facial Injectables Sales 2017-2022 (K Pcs)

Figure 35. Europe Facial Injectables Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Facial Injectables Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Facial Injectables Revenue 2017-2022 ($ Millions)

Figure 38. Americas Facial Injectables Sales Market Share by Country in 2021

Figure 39. Americas Facial Injectables Revenue Market Share by Country in 2021

Figure 40. United States Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Facial Injectables Sales Market Share by Region in 2021

Figure 45. APAC Facial Injectables Revenue Market Share by Regions in 2021

Figure 46. China Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Facial Injectables Sales Market Share by Country in 2021

Figure 53. Europe Facial Injectables Revenue Market Share by Country in 2021

Figure 54. Germany Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Facial Injectables Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Facial Injectables Revenue Market Share by Country in 2021

Figure 61. Egypt Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Facial Injectables Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Facial Injectables in 2021

Figure 67. Manufacturing Process Analysis of Facial Injectables

Figure 68. Industry Chain Structure of Facial Injectables

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390